Curaxys

Curaxys is a biopharmaceutical company specialized in the research, development and production of biosimilar drug. The particularity of Curaxys has been the pioneer in the use of insect cell in the production of biosimilars drug. In fact, up to now the insect cell culture platform has been used for the vaccine production, and never for other therapeutical proteins. Curaxys is also developing new techcnological platform based in other expression system as bacteria, virus and yeast.

The company is developing the recombinants proteins: Insulin, Growth Hormone, Erythropoietin, Granulocyte Colony Stimulating Factor ( GCSF) and the Monoclonal Antibodies(Mab) as : Rituximab, Trastuzumab. The company is located the Technological Park of Puerto de Santa Maria, in Cadiz (Spain). Other therapeutical proteins are under development as the unspecific antibodies.